Press release
Muscle Wasting Disorders Market Size Forecast to USD 45.4 Billion by 2031 with Rising Focus on Rare Disease Therapies - Analysis by Transparency Market Research
Muscle Wasting Disorders Market Outlook 2031
The global muscle wasting disorders market was valued at US$ 12.7 Billion in 2022 and is projected to reach more than US$ 45.4 Billion by the end of 2031, expanding at a CAGR of 15.1% from 2023 to 2031. The market is witnessing rapid growth due to the increasing prevalence of chronic diseases, rising aging population, and advancements in therapeutic approaches for muscle degeneration conditions.
👉 Get your sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39452
Market Overview
Muscle wasting disorders, also known as muscle atrophy conditions, refer to a group of diseases characterized by the progressive loss of muscle mass and strength. These disorders include conditions such as muscular dystrophy, sarcopenia, cachexia, and amyotrophic lateral sclerosis (ALS).
The causes of muscle wasting disorders vary and may include genetic mutations, aging, chronic illnesses such as cancer and kidney disease, neurological disorders, and prolonged immobility. These conditions significantly impact patients' quality of life, mobility, and overall health outcomes.
Treatment approaches typically involve pharmacological therapies, nutritional support, physical therapy, and emerging gene and cell-based therapies. The increasing focus on early diagnosis and targeted treatment options is driving market growth.
Analysis of Key Players in the Muscle Wasting Disorders Market
The muscle wasting disorders market is highly competitive, with pharmaceutical companies and biotechnology firms focusing on drug development, clinical trials, and innovative treatment solutions.
Key companies operating in the global muscle wasting disorders market include:
• Biogen, Inc.
• F. Hoffmann-La Roche Ltd
• Novartis AG
• Ionis Pharmaceuticals, Inc.
• Sarepta Therapeutics, Inc.
• Nippon Shinyaku Co., Ltd. (NS Pharma, Inc.)
• PTC Therapeutics, Inc.
• Teva Pharmaceutical Industries Ltd.
These companies are investing in novel therapeutics, gene therapies, and precision medicine approaches to address unmet medical needs.
Key Developments
• August 2023: The European Commission expanded approval for Evrysdi to include infants with SMA Types 1-3, including newborns under two months.
• June 2023: The U.S. Food and Drug Administration approved Elevidys, the first gene therapy for Duchenne muscular dystrophy (DMD) in pediatric patients aged 4-5 years.
Analysts' Viewpoint on the Global Muscle Wasting Disorders Market
Industry analysts highlight that the growing burden of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is significantly contributing to the rise in muscle wasting disorders globally. Additionally, the aging population is a major factor, as age-related sarcopenia is becoming increasingly common.
Advancements in biotechnology, gene therapy, and regenerative medicine are expected to transform treatment approaches for muscle wasting disorders. Increased research funding, clinical trials, and collaborations between pharmaceutical companies and research institutions are accelerating innovation in this space.
North America dominates the market due to strong healthcare infrastructure and high research investments, while Asia Pacific is expected to witness rapid growth due to improving healthcare access and rising awareness.
👉 Discuss Implications for Your Industry Request Sample Research Report PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39452
Key Player Strategies
💊 Drug Development & Innovation
Focusing on novel therapeutics and advanced treatment options.
🧬 Gene & Cell Therapy Research
Developing targeted therapies for genetic muscle disorders.
🤝 Strategic Collaborations
Partnering with research institutions and biotech firms.
🌍 Global Clinical Trials Expansion
Conducting trials across multiple regions to accelerate approvals.
📊 Investment in Precision Medicine
Developing personalized treatment approaches.
Challenges
• High cost of advanced therapies
• Complex regulatory approval processes
• Limited availability of effective treatments for certain conditions
• Lack of awareness in developing regions
Opportunities
🧬 Advancements in Gene Therapy
Potential breakthroughs in treating genetic muscle disorders.
🏥 Growing Healthcare Investments
Improved access to advanced treatments globally.
📈 Rising Aging Population
Increasing prevalence of age-related muscle loss conditions.
🔬 Expansion of Clinical Research
Growing number of trials focused on innovative therapies.
🌏 Emerging Market Growth
Improving healthcare infrastructure in developing regions.
Market Segmentation
By Disorder Type
• Muscular Dystrophy
• Sarcopenia
• Cachexia
• Amyotrophic Lateral Sclerosis (ALS)
• Others
By Treatment Type
• Drug Therapy
• Nutritional Therapy
• Physical Therapy
• Gene Therapy
By End User
• Hospitals
• Specialty Clinics
• Rehabilitation Centers
By Region
• North America - Leading market with advanced healthcare infrastructure
• Europe - Strong focus on research and innovation
• Asia Pacific - Fastest-growing region due to improving healthcare access
• Latin America
• Middle East & Africa
Why Invest in the Muscle Wasting Disorders Market Outlook 2031
✅ Comprehensive market forecast through 2031
✅ Insights into innovative treatment approaches and pipeline drugs
✅ Competitive landscape with profiles of leading pharmaceutical companies
✅ Regional analysis highlighting high-growth healthcare markets
✅ Identification of emerging opportunities in gene therapy and precision medicine
👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=39452<ype=S
FAQs
1. What is the projected muscle wasting disorders market size by 2031?
The market is expected to exceed US$ 45.4 Bn by 2031.
2. What is the CAGR of the muscle wasting disorders market?
The market is projected to grow at a CAGR of 15.1% from 2023 to 2031.
3. What factors are driving market growth?
Rising prevalence of chronic diseases, aging population, and advancements in treatment technologies.
4. Which region dominates the market?
North America dominates due to strong healthcare infrastructure and research investments.
5. What are key trends in the market?
Gene therapy advancements, precision medicine, increasing clinical trials, and growing focus on early diagnosis.
More Trending Research Reports-
➤ Hypertrophic Cardiomyopathy (HCM) Therapeutics Market - https://www.transparencymarketresearch.com/hypertrophic-cardiomyopathy-therapeutics-market.html
➤ Non-Small Cell Lung Cancer Therapeutics Market - https://www.transparencymarketresearch.com/non-small-cell-lung-cancer-market.html
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact Us
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Muscle Wasting Disorders Market Size Forecast to USD 45.4 Billion by 2031 with Rising Focus on Rare Disease Therapies - Analysis by Transparency Market Research here
News-ID: 4428360 • Views: …
More Releases from Transparency Market Research
Biodiesel Market Size Forecast to USD 187.6 Billion by 2031 with a Focus on Rene …
Biodiesel Market Outlook 2031
The global biodiesel market was valued at US$ 90.4 Billion in 2020 and is projected to reach US$ 187.6 Billion by the end of 2031, expanding at a CAGR of 6.9% from 2021 to 2031. Market growth is driven by increasing demand for renewable fuels, supportive government policies, and rising concerns over carbon emissions and environmental sustainability.
👉 Get your sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=291
Market Overview
Biodiesel…
Wire Harness Market Expanding at 5.9% CAGR Through 2034 - By Application / By Sa …
The global wire harness market is witnessing steady expansion, underpinned by the rapid transformation of industrial and mobility ecosystems. Valued at US$ 88.2 billion in 2023, the market is projected to grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2034, reaching approximately US$ 165.2 billion by the end of 2034.
Preview crucial insights and findings from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=74033
This growth trajectory reflects the…
Dental Aligners Market to be Worth USD 11.3 Bn by 2031 - By Product / By Materia …
The global dental aligners market has witnessed significant growth in recent years, driven by increasing awareness of dental aesthetics and technological advancements in orthodontic treatments. In 2021, the market was valued at US$ 4.6 billion. With strong demand trends and continuous innovation, the market is projected to surpass US$ 11.3 billion by 2031, expanding at a compound annual growth rate (CAGR) of 8.7% during the forecast period from 2022 to…
Thoracic Drainage Devices Market to Surpass USD 1.23 Bn by 2031 Driven by Rising …
The global thoracic drainage devices market is witnessing steady growth, fueled by the increasing prevalence of respiratory and cardiovascular diseases and advancements in medical technologies. Valued at US$ 729.6 Mn in 2021, the market is projected to expand at a CAGR of 5.3% from 2022 to 2031, reaching more than US$ 1.23 Bn by the end of 2031.
Thoracic drainage devices play a critical role in modern healthcare by removing air,…
More Releases for Muscle
Mango AI Reveals an AI Muscle Generator for Muscle Enhancement in Videos
Mango AI has introduced an AI muscle generator (https://mangoanimate.com/ai/ai-muscle) that transforms static photos into videos featuring muscular body reveals. The cutting-edge tool processes images of individuals in casual or formal attire to create animations where the subject removes a shirt to display muscles. Animations in these videos appear natural and align with the original photo's elements.
The AI muscle generator supports photo uploads in formats such as JPG, JPEG, PNG, or…
Artificial Muscle Market Top Players - NAU, Bayer (Artificial Muscle, Inc.), Ste …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Artificial Muscle Market- (By Type (Electric Field Actuation, Pneumatic Actuation, Thermal Actuation), By Application (Industrial, Medical, Consumer, Automotive, Aerospace)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Artificial Muscle Market is valued at US$ 2.23 Bn in 2022, and it is expected to reach US$…
Muscle Protein Powder Market Report Analysis, Research Studies |Vitalstrength, C …
[Nevada, October 2024] - Muscle Protein Powder has emerged as a cornerstone in the health and fitness industry, appealing to athletes, fitness enthusiasts, and even casual gym-goers seeking nutritional support for muscle recovery and growth. Derived from various sources, including whey, casein, soy, and plant-based proteins, these powders provide essential amino acids that aid in muscle synthesis and repair. As the world becomes increasingly health-conscious, the relevance of Muscle Protein…
Sports muscle tape bandage for athletes - Special muscle tape, muscle effect for …
Product Features
Image: https://ecdn6-nc.globalso.com/upload/p/950/image_other/2024-03/66029d7cc0d1029158.png
Pre-slitting muscle patch Knee PadPrevention of muscle strainNo need tocropBody molding without cutting
Image: https://ecdn6-nc.globalso.com/upload/p/950/image_other/2024-03/66029d8a65f1b43114.png
Medical lowsensitivity glue-acrylic glue Not easy to allergy no residueGood stickiness,soft and skin-friendly,comfortable and breathable
Image: https://ecdn6-nc.globalso.com/upload/p/950/image_other/2024-08/1-8.pngImage: https://ecdn6-nc.globalso.com/upload/p/950/image_other/2024-03/66029d83b5f6151157.png
Area-separated design for easy adhesion
Eliminate tedious cropping steps
Image: https://ecdn6-nc.globalso.com/upload/p/950/image_other/2024-03/66029d8f95d8390458.png
High elastic stretch without breaking
Full of elasticity, no sense of restraint in exercise, free stretching is not afraid of breaking product material
Image: https://ecdn6-nc.globalso.com/upload/p/950/image_other/2024-08/product-details-1440-751-px-7.jpg
TECHNICAL Parameters
Product size and weight
Weight
130g
Product attributes
protect part
knee
brand
Xinyouwei
Item number
Muscle tape-knee…
Muscle Wave Pro Review 2023;(Amazing facts!( Is This Muscle Toner Worth It?
Muscle Wave Pro, also known as neuromuscular electrical stimulation or electromyostimulation, is a device that uses electrical impulses to stimulate muscle contractions. It is designed to mimic the natural electrical signals sent by the brain to muscles, causing them to contract and relax.
The basic principle behind Muscle Wave Pro is that electrical stimulation can activate motor nerves, which in turn activate muscles. The device consists of electrodes that are placed…
Artificial Muscle Market Research Report
Artificial muscles, which are also referred to as muscle-like actuators, are devices or materials that copy the functions of human muscle and can expand, contract, vary their stiffness, or rotate due to an external force (current, voltage, temperature, or pressure). There are three basic responses to actuation, expansion, contraction, and rotation. These can then be combined by a single device and used to create further different types of motion.
There…
